NUREG-1566, STC-19-019, NUREG-1566 Volume 13 Revision 2 Consolidated Guidance About Materials Licenses: Program -Specific Guidance About Commercial Radiopharmacy Licenses (Final Report): Difference between revisions

From kanterella
Jump to navigation Jump to search
VisualWikitext
Created page by program invented by StriderTol
 
StriderTol Bot change
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Adams
#REDIRECT [[STC-19-019, NUREG-1566 Volume 13 Revision 2 Consolidated Guidance About Materials Licenses: Program -Specific Guidance About Commercial Radiopharmacy Licenses (Final Report)]]
| number = ML19080A196
| issue date = 03/28/2019
| title = STC-19-019, NUREG-1566 Volume 13 Revision 2 Consolidated Guidance About Materials Licenses: Program -Specific Guidance About Commercial Radiopharmacy Licenses (Final Report)
| author name = Kock A L
| author affiliation = NRC/NMSS
| addressee name =
| addressee affiliation =
| docket =
| license number =
| contact person = McMurtary Anthony MSST/MSLB, 415-2746
| case reference number = STC-19-019
| document type = All Agreement States Letter type:NUREG
| page count = 3
}}

Latest revision as of 05:08, 5 January 2025

Redirect to:

Retrieved from "https://kanterella.com/w/index.php?title=NUREG-1566,_STC-19-019,_NUREG-1566_Volume_13_Revision_2_Consolidated_Guidance_About_Materials_Licenses:_Program_-Specific_Guidance_About_Commercial_Radiopharmacy_Licenses_(Final_Report)&oldid=4934804"